Israel - Renin-Angiotensin System Medicine Use
Since 2014, Israel Renin-Angiotensin System Medicine Use decreased by 1.9% year on year. In 2019, the country was number 24 among other countries in Renin-Angiotensin System Medicine Use at 104.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Israel is overtaken by Portugal, which was number 23 with 121.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Luxembourg with 97.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 0.6% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile was the worst growing country at -3.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 104.80 |
2018 | 107.20 |
2017 | 109.80 |
2016 | 115.60 |
2015 | 111.60 |
How does Israel rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
23 |
#23
Portugal
|
122 | 2019 | +4.8 % | +0.4 % | View data | |
24 |
#24
Israel
|
105 | 2019 | -2.2 % | -1.9 % | View data | |
25 |
#25
Luxembourg
|
98 | 2019 | +0.4 % | -1.4 % | View data |